HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma.

Abstract
Polycomb-group proteins Bmi1 and EZH2 are involved in the malignant transformation and biological aggressiveness of several human carcinomas. We herein examined the significance of the Bmi1 and EZH2 expression in hepatocellular carcinoma (HCC) and its preneoplastic lesions, dysplastic nodules. The expression of Bmi1 and EZH2 were examined immunohistochemically in HCC (n=27) and dysplastic nodules (n=14), and combined hepatocellular and cholangiocarcinoma (HC-CC) (n=14). The effect of Bmi1 and EZH2 knockdown was examined in cultured HCC cells (HuH7 and HepG2) using siRNA. It was determined that Bmi1 was constantly expressed in cholangiocytes, but not in hepatocytes, and EZH2 was detected in neither cholangiocytes nor hepatocytes. Bmi1 and EZH2 were overexpressed in HCC and more extensively in HC-CC (P<0.01). Interestingly, Bmi1 and EZH2 were not overexpressed in the dysplastic nodules. The expression of Bmi1 and EZH2 was heterogeneous and associated with vascular infiltration, the histological grades, and the cell proliferation activity in HCC and HC-CC. In cultured carcinoma cells overexpressing Bmi1 and EZH2, knockdown of Bmi1 and EZH2 resulted in decreased cell proliferation activities. Therefore, the overexpression of polycomb-group proteins Bmi1 and EZH2 is associated with the malignant progression of HCC, thereby reflecting the aggressive biological behavior in HCC and HC-CC.
AuthorsMotoko Sasaki, Hiroko Ikeda, Keita Itatsu, Junpei Yamaguchi, Seiko Sawada, Hiroshi Minato, Tetsuo Ohta, Yasuni Nakanuma
JournalLaboratory investigation; a journal of technical methods and pathology (Lab Invest) Vol. 88 Issue 8 Pg. 873-82 (Aug 2008) ISSN: 1530-0307 [Electronic] United States
PMID18591938 (Publication Type: Journal Article)
Chemical References
  • BMI1 protein, human
  • DNA-Binding Proteins
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • RNA, Small Interfering
  • Repressor Proteins
  • Transcription Factors
  • EZH2 protein, human
  • Enhancer of Zeste Homolog 2 Protein
  • Polycomb Repressive Complex 2
  • Polycomb Repressive Complex 1
Topics
  • Aged
  • Aged, 80 and over
  • Bile Duct Neoplasms (metabolism)
  • Bile Ducts, Intrahepatic (metabolism)
  • Carcinoma, Hepatocellular (metabolism, pathology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Transformation, Neoplastic (metabolism)
  • Cholangiocarcinoma (metabolism)
  • DNA-Binding Proteins (genetics, metabolism)
  • Enhancer of Zeste Homolog 2 Protein
  • Female
  • Humans
  • Immunohistochemistry
  • Liver (metabolism, pathology)
  • Liver Neoplasms (metabolism, pathology)
  • Male
  • Middle Aged
  • Neovascularization, Pathologic (metabolism)
  • Nuclear Proteins (genetics, metabolism)
  • Polycomb Repressive Complex 1
  • Polycomb Repressive Complex 2
  • Proto-Oncogene Proteins (genetics, metabolism)
  • RNA, Small Interfering (genetics)
  • Repressor Proteins (genetics, metabolism)
  • Transcription Factors (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: